These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8795596)

  • 1. Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study.
    Botez MI; Botez-Marquard T; Elie R; Pedraza OL; Goyette K; Lalonde R
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):259-64. PubMed ID: 8795596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of heredo-degenerative ataxias with amantadine hydrochloride.
    Botez MI; Young SN; Botez T; Pedraza OL
    Can J Neurol Sci; 1991 Aug; 18(3):307-11. PubMed ID: 1913365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amantadine hydrochloride treatment in olivopontocerebellar atrophy: a long-term follow-up study.
    Botez MI; Botez-Marquard T; Elie R; Le Marec N; Pedraza OL; Lalonde R
    Eur Neurol; 1999; 41(4):212-5. PubMed ID: 10343152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia.
    Filla A; De Michele G; Orefice G; Santorelli F; Trombetta L; Banfi S; Squitieri F; Napolitano G; Puma D; Campanella G
    Can J Neurol Sci; 1993 Feb; 20(1):52-5. PubMed ID: 8467430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of Friedreich's ataxia with amantadine hydrochloride.
    Peterson PL; Saad J; Nigro MA
    Neurology; 1988 Sep; 38(9):1478-80. PubMed ID: 3412597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxia.
    Bonnet AM; Esteguy M; Tell G; Schechter PJ; Hardenberg J; Agid Y
    Can J Neurol Sci; 1986 Nov; 13(4):331-3. PubMed ID: 3465425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of spinocerebellar ataxias: facts and hypotheses.
    Botez MI; Botez-Marquard T; Mayer P; Marchand L; Lalonde R; Reader TA
    Med Hypotheses; 1998 Nov; 51(5):381-4. PubMed ID: 9848465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Friedreich's ataxia with amantadine.
    Botez MI; Young SN; Rotez T; Courchesne Y
    Neurology; 1989 May; 39(5):749-50. PubMed ID: 2710373
    [No Abstract]   [Full Text] [Related]  

  • 9. Cognitive behavior in heredodegenerative ataxias.
    Botez-Marquard T; Botez MI
    Eur Neurol; 1993; 33(5):351-7. PubMed ID: 8243509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
    Romano S; Coarelli G; Marcotulli C; Leonardi L; Piccolo F; Spadaro M; Frontali M; Ferraldeschi M; Vulpiani MC; Ponzelli F; Salvetti M; Orzi F; Petrucci A; Vanacore N; Casali C; Ristori G
    Lancet Neurol; 2015 Oct; 14(10):985-91. PubMed ID: 26321318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brainstem auditory evoked responses in hereditary spinocerebellar ataxias.
    Knezevic W; Stewart-Wynne EG
    Clin Exp Neurol; 1985; 21():149-55. PubMed ID: 3870433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eye movement disorders in hereditary degenerative ataxia. Electro-oculographic study of 11 cases].
    Serlenga L; Falco F; Castaldo V; Caldarazzo M; Federici A
    Acta Neurol (Napoli); 1992; 14(4-6):440-50. PubMed ID: 1293987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amantadine for Friedreich's ataxia.
    Mariani C; Canesi M; Barbieri S; Pezzoli G
    Neurology; 1990 Jan; 40(1):194. PubMed ID: 2296376
    [No Abstract]   [Full Text] [Related]  

  • 14. Olivopontocerebellar atrophy and Friedreich's ataxia: neuropsychological consequences of bilateral versus unilateral cerebellar lesions.
    Botez-Marquard T; Botez MI
    Int Rev Neurobiol; 1997; 41():387-410. PubMed ID: 9378599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiamine status in inherited degenerative ataxias.
    Pedraza OL; Botez MI
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):136-7. PubMed ID: 1538220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate.
    Nissenkorn A; Hassin-Baer S; Lerman SF; Levi YB; Tzadok M; Ben-Zeev B
    J Child Neurol; 2013 Feb; 28(2):155-60. PubMed ID: 22550086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of efficacy of phosphatidylcholine in ataxias.
    Sorbi S; Piacentini S; Marini P; De Scisciolo G; Amantini A; Amaducci L
    Neurology; 1988 Apr; 38(4):649-50. PubMed ID: 3352929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trapping channel block of NMDA-activated responses by amantadine and memantine.
    Blanpied TA; Boeckman FA; Aizenman E; Johnson JW
    J Neurophysiol; 1997 Jan; 77(1):309-23. PubMed ID: 9120573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
    Quack G; Hesselink M; Danysz W; Spanagel R
    J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Memantine for optic nerve atrophy in Friedreich's Ataxia].
    Peter S; Manousaridis K; Boesch S; Mennel S
    Ophthalmologe; 2016 Aug; 113(8):704-7. PubMed ID: 26666888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.